Catalyst
Slingshot members are tracking this event:
Immunomedics (IMMU) Expects Updated Phase 2 Results for IMMU-130 in Metastatic Colorectal Cancer in 1H 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| IMMU |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 18, 2016
Occurred Source:
http://www.immunomedics.com/pdfs/news/2016/pr04182016a.pdf
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Updated Results, Phase 2 Data, Immu-130, Metastatic Colorectal Cancer, 1h 2016
